文献速递其他结缔组织病

早期胃肠道表现预测系统性硬化症疾病进展与死亡

Early gastrointestinal manifestations predict disease progression and mortality in patients with systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

基于GENISOS队列450例早期系统性硬化症患者,基线GERD和腹泻是显著胃肠道进展的强预测因素,消化性溃疡和腹泻预测死亡率升高,基线胃肠道症状负担每增加一项,进展风险增加53%,死亡风险增加29%。

要点

  • 基线GERD(HR 4.15)和腹泻(HR 2.25)预测显著胃肠道进展。
  • 消化性溃疡(HR 2.21)和腹泻(HR 1.48)预测全因死亡率升高。
  • 每增加一项基线胃肠道症状,进展风险增加53%,死亡风险增加29%。

核心结论

  • 早期胃肠道症状及总体症状负担可预测SSc患者的胃肠道进展和死亡。
  • 基于症状的分析可能为临床风险分层和试验富集提供实用策略。

研究设计与样本

  • 来自GENISOS队列的450例早期SSc患者(距首个非雷诺症状≤5年),基线评估人口学与临床变量包括个体胃肠道症状,采用Cox模型评估基线症状与显著胃肠道疾病进展及全因死亡的关系。

主要发现

  • 基线胃肠道症状常见,最常见为GERD(76%)和吞咽困难(41%)。
  • 13%的患者有显著胃肠道受累,其中4%在基线即存在显著胃肠道疾病。
  • 基线GERD(HR 4.15,P=0.019)和腹泻(HR 2.25,P=0.021)是胃肠道进展的强预测因素。
  • 每增加一项基线胃肠道症状,显著胃肠道进展风险增加53%(P=0.003)。
  • 消化性溃疡(HR 2.21,P=0.007)和腹泻(HR 1.48,P=0.045)预测死亡率升高,每增加一项症状死亡风险增加29%(P<0.001)。

关键数值与推荐

  • 显著胃肠道受累定义为Medsger胃肠道严重度评分≥2。

临床怎么用

  • 对早期SSc患者应详细采集GERD、腹泻、消化性溃疡等胃肠道症状,用于风险分层。
  • 症状负担可作为临床试验富集的参考依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Gastrointestinal (GI) complications are common in systemic sclerosis (SSc), yet the value of early symptoms as predictors of progression remains poorly defined. We aimed to determine whether baseline GI symptoms in early SSc predict progression to significant GI outcomes. METHODS: We studied 450 participants from the GENISOS cohort with early SSc (≤5 years from first non-Raynaud's symptom). Baseline assessments included demographics and clinical variables, including individual GI symptoms (gastroesophageal reflux disease [GERD], dysphagia, bloating, constipation, diarrhoea, peptic ulcer). Significant GI involvement was defined as Medsger GI severity score ≥2. Cox models evaluated associations between baseline symptoms and progression to significant GI disease and all-cause mortality. Additional models examined total baseline GI symptom burden and outcomes. RESULTS: Participants were predominantly female (84%) with a mean age of 47.7 (13.3) years. Baseline GI symptoms were frequent, most commonly GERD (76%) and dysphagia (41%). Thirteen per cent of the patients had significant GI involvement, with 4% presenting with significant GI disease at baseline. Baseline GERD (hazard ratio [HR] 4.15, P = 0.019) and diarrhoea (HR 2.25, P = 0.021) were strong predictors of GI progression. When symptom burden was analysed, each additional baseline GI symptom increased the hazard of significant GI progression by 53% (P = 0.003). On the other hand, peptic ulcer disease (HR 2.21, P = 0.007) and diarrhoea (HR 1.48, P = 0.045) predicted higher mortality, with each additional symptom raising mortality risk by 29% (P < 0.001). CONCLUSION: Early GI symptoms and overall symptom burden predict GI progression and mortality in SSc. Symptom-based profiling may offer a practical strategy for clinical risk stratification and trial enrichment.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Ayla AY, Balar AP, Calderon Martinez E, et al. Early gastrointestinal manifestations predict disease progression and mortality in patients with systemic sclerosis. Rheumatology (Oxford). 2026. PMID: 42143732. doi:10.1093/rheumatology/keag257

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。